Literature DB >> 8103823

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

A M Saunders1, K Schmader, J C Breitner, M D Benson, W T Brown, L Goldfarb, D Goldgaber, M G Manwaring, M H Szymanski, N McCown.   

Abstract

The frequency of the allele for apolipoprotein E type 4 (epsilon 4) is increased in late-onset familial and sporadic Alzheimer's disease (AD). We have examined epsilon 4 frequencies in four distinct, normal, elderly control groups and, most importantly, in patients with amyloid-forming diseases whose epsilon 4 distributions were not previously known (Creutzfeldt-Jakob disease, familial amyloidotic polyneuropathy, Down's syndrome). There were no differences between any of these controls and published control series, cementing the relevance of epsilon 4 for late-onset AD. The increase in late-onset AD was confirmed in two new series.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103823     DOI: 10.1016/0140-6736(93)91709-u

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  113 in total

1.  Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity.

Authors:  M Tolar; J N Keller; S Chan; M P Mattson; M A Marques; K A Crutcher
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

2.  Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated.

Authors:  M Tolar; M A Marques; J A Harmony; K A Crutcher
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

3.  Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.

Authors:  David J Moore; Miguel Arce; Suzanne Moseley; J Allen McCutchan; Jennifer Marquie-Beck; Donald R Franklin; Florin Vaida; Cristian L Achim; Justin McArthur; Susan Morgello; David M Simpson; Benjamin B Gelman; Ann C Collier; Christina M Marra; David B Clifford; Robert K Heaton; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

4.  APOE ϵ4, rated life experiences, and affect among centenarians.

Authors:  Peter Martin; S Michal Jazwinski; Adam Davey; Robert C Green; Maurice Macdonald; Jennifer A Margrett; Ilene C Siegler; Jonathan Arnold; John L Woodard; Mary Ann Johnson; Sangkyu Kim; Jianliang Dai; Li Li; Mark A Batzer; Leonard W Poon
Journal:  Aging Ment Health       Date:  2013-09-02       Impact factor: 3.658

5.  Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.

Authors:  S Sauder; H Kölsch; D Lütjohann; A Schulz; K von Bergmann; W Maier; R Heun
Journal:  J Neural Transm (Vienna)       Date:  2005-01-24       Impact factor: 3.575

6.  Apolipoproteins E and C1 and brain morphology in memory impaired elders.

Authors:  J M Serra-Grabulosa; P Salgado-Pineda; C Junqué; C Solé-Padullés; P Moral; A López-Alomar; T López; A López-Guillén; N Bargalló; J M Mercader; I C Clemente; D Bartrés-Faz
Journal:  Neurogenetics       Date:  2002-12-21       Impact factor: 2.660

Review 7.  Antioxidant therapy in Alzheimer's disease: theory and practice.

Authors:  Gjumrakch Aliev; Mark E Obrenovich; V Prakash Reddy; Justin C Shenk; Paula I Moreira; Akihiko Nunomura; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Mini Rev Med Chem       Date:  2008-11       Impact factor: 3.862

8.  Apolipoprotein ε4-allele as a significant risk factor for conversion from mild cognitive impairment to Alzheimer's disease: a meta-analysis of prospective studies.

Authors:  Ma Fei; Wang Jianhua
Journal:  J Mol Neurosci       Date:  2012-12-15       Impact factor: 3.444

9.  A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.

Authors:  Pu-Ting Xu; Yi-Ju Li; Xue-Jun Qin; Charles Kroner; Anya Green-Odlum; Hong Xu; Tian-Yuan Wang; Donald E Schmechel; Christine M Hulette; John Ervin; Mike Hauser; Jonathan Haines; Margaret A Pericak-Vance; John R Gilbert
Journal:  Mol Cell Neurosci       Date:  2007-07-24       Impact factor: 4.314

10.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.